The membrane-bound mucin, MUC4, which is expressed as early as PanIN-1A but is not expressed in the healthy pancreas, and its membrane partner, the oncogenic receptor ErbB2, which is frequently overexpressed in pancreatic cancer as well as in PanINs, represent promising therapeutic targets [37,38]. Here, MUC4 is linked to pancreatic neoplasm.